ProQR Therapeutics (PRQR) Capital Leases (2013 - 2015)

ProQR Therapeutics (PRQR) has reported Capital Leases for 3 consecutive years, with $21648.1 the latest figure, recorded in Q4 2015.

• Quarterly Capital Leases fell 55.88% year-over-year to $21648.1 in Q4 2015, while the trailing twelve-month figure through Dec 2015 was $21648.1 (down 55.88% YoY) and the FY2015 annual result came in at $21648.1, down 55.88% from the prior year.
• Capital Leases eased to $21648.1 in Q4 2015 per PRQR's latest filing, from $43296.3 in the prior quarter.
• Over the last five years, Capital Leases for PRQR reached as high as $69274.1 in Q4 2013 and fell as low as $21648.1 in Q4 2015.
• A 3-year average of $48491.8 and a median of $49069.1 in 2014 frame the typical range for Capital Leases.
• Annual changes were most pronounced in 2014 — Capital Leases dropped 29.17% — and 2015, when it sank 55.88%.
• Year by year, Capital Leases stood at $69274.1 in 2013, then decreased by 29.17% to $49069.1 in 2014, then plunged by 55.88% to $21648.1 in 2015.
• According to Business Quant data, Capital Leases over the past three periods registered $21648.1, $43296.3, and $49069.1 for Q4 2015, Q1 2015, and Q4 2014 respectively.